Funding for COVID-19 Research – Updated 4/9/20

General Funding Resources

InfoEd Global

• COVID-19/Coronavirus Resources (updated continually)
• Spin Global Suite

Federal Funding

Agency for Healthcare Research and Quality

• Notice of Intent: New Funding Opportunity Announcement to Support Novel, High-Impact Studies Evaluating Health System and Healthcare Professional Responsiveness to COVID-19 (March 26)

Biomedical Advanced Research and Development Authority (BARDA)

• Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA) (April 30)
  • The solicitation notes that “the diagnostics must utilize platforms already cleared by the U.S. Food and Drug Administration, with a viable plan to meet requirements for the FDA to consider Emergency Use Authorization (EUA) within 12 weeks of an award.”

Center for Disease Control and Prevention (CDC)

• Information for CDC Applicants and Recipients of CDC Funding (continually updated: funding opportunities and guidance)
• Centers for Disease Control COVID-19 Broad Agency Announcement (March 25)
• Strengthening Public Health Systems and Services through National Partnerships to Improve and Protect the Nations Health (March 20)

Defense Advanced Research Projects Agency (DARPA)

• SBIR/STTR Opportunity: Rapid, flexible manufacturing of DNA molecules for synthetic biology and therapeutic applications (March 3)

Defense Logistics Agency (DLA)

• DLA’s Technology Accelerator OTA Program (Closes May 4)

Department of Defense (DOD)

• xTech COVID-19 Ventilator Challenge (Submit by April 13)
• High Performance Computing, Modeling, and Simulation Projects (Concept Papers due April 30)
• Newton Award for Transformative Ideas during the COVID-19 Pandemic (April 3)
• Joint Acquisition Task Force (JATF) (April 3)
• Small Business Innovation Research (SBIR) Program X20.R SBIR Commercial Solutions Opening (CSO) AF Ventures Direct to Phase II (March 30)
• Prototype Development to Combat Novel Coronavirus Disease COVID-19 (April 15)
• Request for Information for PPE in response to COVID-19 (March 24)
• (Intent and Direction) Engaging the Research and Development Industrial Base during COVID-19 (March 24)

Department of Energy (DOE)

• COVID-19 HPC Consortium (April 1)
• Dear Colleague Letter (March 12)
• The COVID-19 High Performance Computing Consortium (March 22)

Medical CBRN Defense Consortium (MCDC)

• CoV Pandemic Response (March 19 – May 31)

National Aeronautics and Space Administration (NASA)

• Rapid Response and Novel Research in Earth Science (April 1)

National Center for Advancing Translational Sciences (NCATS)

• Notice of Special Interest (NOSI): Repurposing Existing Therapeutics to Address the 2019 Novel Coronavirus Disease (COVID-19) (March 27)
• Notice of Special Interest (NOSI): Clinical and Translational Science Award (CTSA) Program Applications to Address 2019 Novel Coronavirus (COVID-19) Public Heath Need (March 24)

National Endowment for the Arts (NEA)

• National Endowment for the Arts to Distribute $75 million in Relief Aid to Arts Organizations in Need (March 27)

National Heart, Lung, and Blood Institute (NHLBI)

• Notice of Special Interest (NOSI): Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19) (March 17)

National Human Genome Research Institute (NHGRI)

• Notice of NHGRI’s Participation in PA-18-935 “Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement – Clinical Trial Optional)” (March 31)
• Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus (March 31)

National Institute of Allergy and Infectious Disease (NIAID)

• Notice of Special Interest (NOSI): Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (March 27)
• Investigator Initiated Extended Clinical Trial (R01 Clinical Trial Required) (March 13)
• Partnerships for Countermeasures against Select Pathogens (R01 Clinical Trials Not Allowed) (March 11)
• Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus (2019-nCoV) (February 6)
• NIAID’s Multi-Pronged Response to the COVID-2019 Outbreak (February 19)
• 2020 NIAID Omnibus Broad Agency Announcement (April 9)

National Institute on Aging (NIA)

• Notice of Special Interest (NOSI): NIA Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19) (April 2)

National Institute on Drug Abuse (NIDA)

• Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus (March 19) (supplement to existing awards)

National Institute of Environmental Health Sciences (NIEHS)

• Notice of Special Interest: NIEHS Worker Training Program Coronavirus and Infectious Disease Response Training (Admin Supp Clinical Trial Not Allowed) (March 27)

National Institute of General Medical Science (NIGMS)

• Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on Coronavirus Disease 2019 (COVID-19) and the Causative Virus SARS-CoV-2 (March 25)

National Institutes of Health (NIH)

• Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement – Clinical Trial Optional) (March 10)
• Collaborative Cross (CC) Mouse Model Generation and Discovery of Immunoregulatory Mechanisms (R21 Clinical Trial Not Allowed) (February 6) (Rolling basis)
• Partnerships for Countermeasures against Select Pathogens (R01 Clinical Trials Not Allowed) (March 11)
• Collaborative Cross (CC) Mouse Model Generation and Discovery of Immunoregulatory Mechanisms (R21 Clinical Trial Not Allowed) (September 9)
• Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement – Clinical Trial Optional) (Continuous Submission)
• Investigator Initiated Extended Clinical Trial (R01 Clinical Trial Required) (May 13)
• Search the NIH Funding Database for more “COVID-19” research funding opportunities.

National Institute for Health Research (NIHR)

• Travel and Subsistence Funding to Support LMIC Engagement During the COVID-19 Outbreak – Applicant Guidance (May 30) (continuous submission)

National Institute of Standards and Technology (NIST)

• NIST Funding Manufacturing Institutes to Support Pandemic Response (March 31)

National Science Foundation (NSF)

• Dear Colleague Letter: Provisioning Advanced Cyberinfrastructure to Further Research on the Coronavirus Disease 2019 (COVID-19) (March 5) (Before submitting a RAPID proposal or supplemental funding request in response to this DCL, investigators must first contact one of the cognizant OAC program officers listed.)
• Dear Colleague Letter on the Coronavirus Disease 2019 (COVID-19) (April 3)
•  Frequently Asked Questions (FAQs) regarding the NSF Dear Colleague Letter on the Coronavirus Disease 2019 (COVID-19) (NSF 20-052) (March 17)

Beginning on April 7, we will stop updating the Non-federal Funding section since the Office of Corporate and Foundation Relations will post that information to their website. We will link to their website as soon their update becomes available.

Non-federal Funding

American Heart Association

• AHA Rapid Response Grant COVID-19 and Its Cardiovascular Impact (Closes April 6)

Amazon

• AWS Diagnostic Development Initiative (DDI) (Closes June 30)

Bill & Melinda Gates Foundation

• Bill & Melinda Gates Foundation, Wellcome, and Mastercard Launch Initiative to Speed Development and Access to Therapies for COVID-19 (March 10)

Bloomberg Philanthropies

• Coronavirus Response

C3.ai Digital Transformation Institute

• Mitigation of COVID-19 and Future Pandemics (May 1 Deadline)

Chan Zuckerberg Initiative

• CZI Coronavirus Response

Harrington Foundation Discovery Institute

• Harrington Scholar Award for Coronavirus (Closes April 30)

Johns Hopkins University

• Fast-Track Grant For Research on Non-Animal Approaches to Investigate Mechanisms, Medicines, and Vaccines for Coronaviruses (April 30)

Life Arc

• Funding available for the development and testing of therapeutics to treat COVID-19 (Closes April 6)

Luminary Labs

• COVID-19 open innovation index (Various opportunities, continually updated)

Massachusetts General Hospital (MGH)

• Innovate2Ventilate: An Open Innovation Effort to Design a Rapidly Deployable Mechanical Ventilator (May 1 deadline)

Massachusetts Institute of Technology

• Health Security & Pandemics (Closes June 18)

Novartis

• Novartis announces broad range of initiatives to respond to COVID-19 Pandemic; Creates USD 20 million global fund to support impacted communities (March 17)

Russell Sage Foundation

• Funding Opportunities – How to Apply (Closing May 21)

United Way of Greater Nashville

• COVID-19 Response Fund (April 8)

Wellcome Trust

• Epidemic Preparedness: COVID-19 funding call (Currently Closed)

XSEDE

• COVID-19 HPC Consortium (April 3)